Repligen RGEN · NASDAQ
$178.94 +3.14% (+$5.45)
Summary
35 / 100 · Bulios Score
What speaks for it
- It holds more cash than debt: $727.0M against $692.2M.
- Out of every 100 USD of revenue, 13 USD is left as free cash.
- Analysts expect revenue to grow by 15% this fiscal year.
What to watch
- The company made a loss over the last 12 months.
- Earnings per share fell by 36% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 15% a year over 5 years. Over the last 3 years it fell by 2.7% a year. For the next fiscal year analysts expect revenue to grow by 15%. Earnings per share fell by 36% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyOver the last 12 months it made a loss of $11.8M.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 6.5 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 22
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $188.67 is 5.4% above today's price. 92% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product 50%
- Filtration Products 27%
- Chromatography Products 10%
- Proteins Products 6.6%
- Process Analytics Products 5.5%
- Other 0.2%
By region
The company reports no revenue by region.
Product brings in 50% of revenue. Process Analytics Products grew fastest, by 14% a year.
Segments in detail